MedPath

effects of Progesterone by vaginal suppository to reduce preterm birth in women at risk

Phase 3
Conditions
Preterm delivery.
Pregnancy, childbirth and the puerperium
(O00-O99)
Registration Number
IRCT201108286808N2
Lead Sponsor
Birjand University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
56
Inclusion Criteria

cervical insufficiency, history of premature labor and uterine abnormalities.

Exclusion criteria :
fetal abnormalities, preeclampsia, and sensitivity to progesterone

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of days delay in delivery of prescribed suppositories. Timepoint: during labor. Method of measurement: Counting the days.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath